CAPRICOR THERAPEUTICS INC (CAPR)
US14070B3096 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 240K -22.58% | 2.55M 962.50% | 25.178M 887.38% | 17.109M -32.05% | 29.915M 74.85% | 103.72M 246.72% | 178.7M 72.29% | 295.91M 65.59% | 407.26M 37.63% | 570.71M 40.13% | 728.44M 27.64% | |
| EBITDA YoY % growth | -15.59M -53.60% | -21.7M -39.19% | -4.341M 80.00% | -46.512M -971.46% | -52.122M -12.06% | -9.282M 82.19% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.84M -53.94% | -22.23M -40.34% | -5.41M 75.66% | -46.539M -760.26% | -41.737M 10.32% | 19.238M 146.09% | 61.757M 221.02% | 171.53M 177.75% | 240.74M 40.35% | 374.14M 55.41% | 499.92M 33.62% | |
| Operating Margin | -6,600.00% | -871.76% | -21.49% | -272.01% | -139.52% | 18.55% | 34.56% | 57.97% | 59.11% | 65.56% | 68.63% | |
| EPS YoY % growth | -0.87 7.45% | N/A -41.28% | -0.87 29.22% | -1.32 -51.24% | -1.03 21.48% | 0.41 139.99% | 0.63 51.85% | -0.44 -169.92% | 0.98 323.26% | 3.44 251.04% | 4.60 33.83% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 -1,285.52% | -0.37 -19.55% | -0.40 -14.63% | -0.39 -3.79% | -0.32 -16.56% |
| Revenue Q2Q % growth | 5.795M -52.06% | 2.21M -54.96% | 2.21M -44.35% | 2.21M -2.30% | 6.341M 9.42% |
| EBITDA Q2Q % growth | -13.056M -6,046.60% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.531M -721.93% | -15.334M -49.37% | -16.626M -43.44% | -14.45M -11.07% | -13.787M -30.91% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.38 -52.00% | -0.37 | -0.01 | -3.97% |
| Q2 2024 Q2Q % growth | -0.35 -20.69% | -0.36 | 0.01 | 3.61% |
| Q1 2024 Q2Q % growth | -0.31 | -0.12 | -0.19 | -168.17% |
| Q4 2023 Q2Q % growth | -0.02 93.55% | -0.09 | 0.07 | 78.21% |
| Q3 2023 Q2Q % growth | -0.25 3.85% | -0.30 | 0.05 | 15.48% |
| Q2 2023 Q2Q % growth | -0.29 | -0.36 | 0.07 | 18.77% |
| Q1 2023 Q2Q % growth | -0.31 3.13% | -0.33 | 0.02 | 5.02% |
| Q4 2022 Q2Q % growth | -0.31 -19.23% | -0.34 | 0.03 | 9.28% |
| Q3 2022 Q2Q % growth | -0.26 -52.94% | -0.30 | 0.04 | 13.10% |
| Q2 2022 Q2Q % growth | -0.29 -38.10% | -0.26 | -0.03 | -11.50% |
| Q1 2022 Q2Q % growth | -0.32 -39.13% | % | ||
| Q4 2021 Q2Q % growth | -0.26 -23.81% | -0.19 | -0.07 | -34.16% |
| Q3 2021 Q2Q % growth | -0.17 15.00% | -0.22 | 0.05 | 24.24% |
| Q2 2021 Q2Q % growth | -0.21 8.70% | -0.23 | 0.02 | 10.49% |
| Q1 2021 Q2Q % growth | -0.23 23.33% | % | ||
| Q4 2020 Q2Q % growth | -0.21 38.24% | -0.20 | -0.01 | -2.94% |
| Q3 2020 Q2Q % growth | -0.20 53.49% | -0.38 | 0.18 | 47.01% |
| Q2 2020 Q2Q % growth | -0.23 61.02% | -0.38 | 0.15 | 39.06% |
| Q1 2020 Q2Q % growth | -0.30 62.50% | -0.34 | 0.04 | 10.87% |
| Q4 2019 Q2Q % growth | -0.34 69.09% | -0.35 | 0.01 | 1.96% |
| Q3 2019 Q2Q % growth | -0.43 69.29% | -0.71 | 0.28 | 39.78% |
| Q2 2019 Q2Q % growth | -0.59 57.86% | -0.82 | 0.23 | 27.70% |
| Q1 2019 Q2Q % growth | -0.80 42.86% | -1.12 | 0.32 | 28.70% |
| Q4 2018 Q2Q % growth | -1.10 | -1.63 | 0.53 | 32.60% |
| Q3 2018 Q2Q % growth | -1.40 | -1.48 | 0.08 | 5.34% |
| Q2 2018 Q2Q % growth | -1.40 | -1.28 | -0.13 | -9.80% |
| Q1 2018 Q2Q % growth | -1.40 | -1.22 | -0.18 | -14.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.262M -63.43% | 3.64M | -1.378M | -37.86% |
| Q2 2024 Q2Q % growth | 3.971M 1.39% | 3.737M | 234.44K | 6.27% |
| Q1 2024 Q2Q % growth | 4.907M 64.33% | 9.894M | -4.987M | -50.41% |
| Q4 2023 Q2Q % growth | 12.088M 1,159.17% | 10.812M | 1.276M | 11.80% |
| Q3 2023 Q2Q % growth | 6.186M 289.04% | 3.228M | 2.958M | 91.63% |
| Q2 2023 Q2Q % growth | 3.917M | 1.53M | 2.387M | 156.01% |
| Q1 2023 Q2Q % growth | 2.986M | 510K | 2.476M | 485.49% |
| Q4 2022 Q2Q % growth | 960K | 5.1K | 954.9K | 18,723.53% |
| Q3 2022 Q2Q % growth | 1.59M | 214.2K | 1.376M | 642.30% |
| Q2 2022 Q2Q % growth | -100.00% | 397.8K | -397.8K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | 214.2K | -214.2K | -100.00% |
| Q2 2021 Q2Q % growth | 200K 300.00% | 214.2K | -14.2K | -6.63% |
| Q1 2021 Q2Q % growth | 40K -78.95% | % | ||
| Q4 2020 Q2Q % growth | 60K -72.73% | 213.149K | -153.149K | -71.85% |
| Q3 2020 Q2Q % growth | 20K -85.71% | 213.149K | -193.149K | -90.62% |
| Q2 2020 Q2Q % growth | 50K -87.80% | 214.2K | -164.2K | -76.66% |
| Q1 2020 Q2Q % growth | 190K -17.39% | 214.2K | -24.2K | -11.30% |
| Q4 2019 Q2Q % growth | 220K -66.15% | 35.7K | 184.3K | 516.25% |
| Q3 2019 Q2Q % growth | 140K -36.36% | 204K | -64K | -31.37% |
| Q2 2019 Q2Q % growth | 410K 2.50% | 224.4K | 185.6K | 82.71% |
| Q1 2019 Q2Q % growth | 230K -42.50% | 438.6K | -208.6K | -47.56% |
| Q4 2018 Q2Q % growth | 650K | 117.3K | 532.7K | 454.13% |
| Q3 2018 Q2Q % growth | 220K | 459K | -239K | -52.07% |
| Q2 2018 Q2Q % growth | 400K | 209.1K | 190.9K | 91.30% |
| Q1 2018 Q2Q % growth | 400K | 499.8K | -99.8K | -19.97% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -81.11% | -81.11% | -3.78% | -6.42% |
| Revenue | -43.72% | -43.72% | -8.52% | -21.2% |